Impella device 

The Impella device is a mechanical circulatory support (MCS) that provides temporary circulatory assistance to individuals with severe cardiac failure. The device is used as a bridge to heart transplant for patients who are critically ill and need mechanical support to survive until a donor heart is available. The Impella device works by taking over the function of the heart and circulating blood to other body parts.

Overview of Impella

Impella is a mechanical circulatory support that utilizes a catheter to reduce the strain on the heart. The Impella device, therefore, differs from other mechanical circulatory support devices that are implanted surgically. Moreover, the Impella device is recommended for use in patients presenting with cardiogenic shock or acute decompensated heart failure. Some of the common indications for using the Impella device as a bridge to heart transplant include cardiogenic shock, acute decompensated heart failure, end-stage heart failure, post-surgical heart failure, severe myocardial infarction, and refractory arrhythmia.

Indications for Impella as a Bridge to Heart Transplant

Cardiogenic Shock

Cardiogenic shock is characterized by reduced blood flow to the body thus leading to multiple organ failure. The Impella device can be used to provide temporary circulatory assistance to patients presenting with cardiogenic shock and need to bridge to heart transplant.

Acute Decompensated Heart Failure

Acute decompensated heart failure occurs when the heart is unable to maintain adequate blood pressure and perfusion to other body parts. Patients with acute decompensated heart failure usually present with an increased risk of developing cardiogenic shock. In addition to being a bridge to heart transplant, the Impella device can be used to provide temporary circulatory support to patients with acute decompensated heart failure.

End-stage Heart Failure

Patients with end-stage heart failure who are awaiting heart transplantation can also benefit from the Impella device. The device offers temporary mechanical circulatory support to patients with end-stage heart failure.

Post-surgical Heart Failure

Post-surgical heart failure refers to heart failure that develops as a result of heart surgery. Patients undergoing heart surgery usually present with an increased risk of developing post-surgical heart failure. Such patients can benefit from using the Impella device as a bridge to heart transplant.

Severe Myocardial Infarction

Myocardial infarction (MI) is a severe condition that occurs due to the blockage of blood supply to the heart. Severe MI can lead to cardiogenic shock, thereby necessitating the use of the Impella device as a bridge to heart transplant. The Impella device can also help post-MI patients who require a heart transplant to survive until a suitable donor heart is available.

Refractory Arrhythmias

Refractory arrhythmias are abnormally low or high heartbeats that develop in the setting of heart failure or cardiac arrest. Patients presenting with refractory arrhythmias can benefit from the Impella device as a bridge to heart transplant.

How does Impella work as a Bridge to Heart Transplant?

The Impella device is used as a bridge to heart transplant to provide temporary circulatory assistance to patients with cardiogenic shock, acute decompensated heart failure, and other heart conditions that require a heart transplant. The Impella device provides hemodynamic support to the patient. Hemodynamic support refers to providing support to increase the patient’s cardiac output and maintain organ perfusion. Organ perfusion is necessary to ensure that the patient’s critical organs such as the brain, kidney, and liver receive adequate blood supply. Organ perfusion by the Impella device is essential to promote patient survival, especially when a donor heart is unavailable. Another advantage of the Impella device is that it provides circulatory assistance that helps maintain the oxygenation of the patient’s organs. Moreover, the Impella device can help to reduce the risk of developing other life-threatening conditions. For example, the Impella device prevents organ dysfunction by helping to maintain the perfusion of the vital organs.

Bridge to Recovery or Heart Transplant

The Impella device can help promote recovery among heart failure patients. Although the primary indication for the Impella device is as a bridge to heart transplant, the device is also used as a bridge to recovery in some patients. The Impella device is, however, mainly used as a bridge to heart transplant for patients with heart failure who require a heart transplant to survive.

Procedure for Impella Insertion

The Impella procedure is a minimally invasive procedure that can be performed within a few hours. The Impella device is usually inserted via a catheter that is advanced through the femoral artery to the left ventricle to provide temporary circulatory assistance to the patient.

Benefits of Impella as a Bridge to Heart Transplant

Life-saving Circulatory Assistance

The Impella device provides life-saving circulatory assistance to patients with cardiogenic shock or acute decompensated heart failure who need to bridge to heart transplant.

Minimally Invasive

The Impella procedure is a minimally invasive procedure, thus eliminating the need for making incisions on the patient’s chest during the surgery. The minimally invasive nature of the Impella procedure reduces the possibility of surgical complications.

Protect Other Organs

The Impella device helps to protect other organs such as the kidney and liver by providing adequate perfusion and oxygenation to the patient’s organs. Protecting the patient’s organs is critical for successful heart transplant surgery.

Improved Outcomes Following Transplant Surgery

The Impella device can also improve the patient’s transplant outcomes by improving the patient’s overall condition prior to the heart transplant surgery. Moreover, the use of the Impella device can reduce the possibility of transplant-related complications following surgery.

Bridge to Recovery

The Impella device can help promote patient recovery by helping the patient’s heart to recover. The ability of the Impella device to promote patient recovery helps to reduce the length of hospitalization among patients who need a heart transplant.

Risks and Complications of Impella Use

Bleeding

The use of the Impella device can cause life-threatening bleeding in the patient’s body.

Infection

The Impella device can also cause severe infections that may be fatal to the patient. In addition, infection following the use of the Impella device may necessitate the patient to be admitted to the hospital.

Vascular Injury

The Impella device can cause vascular injury that may also be life-threatening to the patient.

Hemolysis

The Impella device can cause hemolysis, a condition that occurs when the red blood cells are destroyed.

Device Malfunction

Malfunction of the Impella device is also a serious concern following use of the device since it can cause severe complications and even death.

Stroke

The Impella device can cause stroke that can be fatal to the patient.

Kidney Injury

The Impella device can cause kidney injury and may require the patient to be admitted to the hospital.

Post-Impella and Heart Transplant Surgery

Following the use of the Impella device, the patient must undergo heart transplant surgery. Moreover, the patient may need to be admitted to the hospital to ensure that there are no post-impella or transplant-related complications following the use of the device and transplant surgery. The patient may also need to take immunosuppressive drugs to prevent the patient’s immune system from rejecting the donor heart. Cardiac rehabilitation is the final step for patients who have undergone heart transplant and is critical for their recovery.

Prognosis and Survival Rates

The prognosis of heart transplant surgery while using the Impella device as a bridge to transplant is generally positive, with most patients surviving the surgery and the following rehabilitation process. The survival rate of heart transplant procedures while using the Impella device is about 80-90%, which is significantly higher than those recorded for heart transplant procedures performed without the use of the Impella device.

Conclusion

The Impella device is a useful device that offers temporary mechanical circulatory support to heart failure patients. The device helps to improve the patient’s condition prior to heart transplant surgery and also reduces the possibility of transplant-related complications following surgery. The Impella device, however, carries certain risks and complications that must be understood by the patient prior to using the device as a bridge to heart transplant.